Secretary Robert F. Kennedy Jr. | HSS Secretary Robert F. Kennedy Jr. has signed off on a recommendation from an advisory ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...

Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...

For many contract manufacturers, the end of the COVID-19 pandemic—and the production contracts that came with it—marked a ...

A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their ...

Taiwanese drugmaker Orient Pharma and AvKARE of Tennessee have each initiated separate recalls of the high cholesterol drug ...

That includes the concept of microfeminism, where Pelletier admitted to being “a little bit nervous” about “swinging for the ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions. The company’s series D fundraise was led by Suvretta Capital Management and SR One ...

The PMCPA ruled that “a systemic failure in compliance oversight” at Theramex has brou | The PMCPA ruled that “a systemic ...

A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand. | A brief skirmish between ...